1.17
+0.0176(+1.53%)
Currency In USD
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1012
First IPO Date
June 16, 2022
| Name | Title | Pay | Year Born |
| Mr. Robert Wessman | Chief Executive Officer, Founder & Executive Chairman | 2.32M | 1970 |
| Ms. Tanya Zharov | General Counsel | 0 | 1967 |
| Mr. Giedrius Zunda | Chief Technical Officer | 0 | N/A |
| Mr. Joel Morales | Chief Financial Officer | 0 | 1978 |
| Mr. Anil Okay | Chief Commercial Officer | 0 | 1986 |
| Mr. Joseph E. McClellan | Chief Scientific Officer | 0 | 1974 |
| Ms. Jenny Sif Steingrimsdottir | Vice President of People & Culture | 0 | N/A |
| Mr. Anthony M. Maffia III | Chief Regulatory Affairs Officer | 0 | N/A |
| Mr. Benedikt Stefansson | Vice President of Investor Relations and Global Communications | 0 | N/A |
| Mr. Faysal Kalmoua | Chief Operating Officer & Director | 0 | 1976 |
Alvotech Holdings SA, through its subsidiaries, develops and manufactures biosimilars for global markets. The company is based in Iceland.